|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor显示文摘 | Riccioni R Dupuis ML Bernabei M | 2010 | Blood Cells Mol Dis2010，45，1： | 1 |
| 2 | Plasmid DNA adsorbed onto cationic micropartieles mediates target gene expression and antigen presentation by dendritic cells 显示文摘 | Denis-Mize KS Dupuis M MacKichan ML | 2000 | Gene Therapy2000，7，24： | 1 |
| 3 | The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor显示文摘 | Riccioni R Dupuis ML Bernabei M | 2010 | Blood Cells Mol Dis2010，45，1： | 1 |
| 4 | The cancer stem cell selec- tive inhibitor salinomycin is a p-glycoprotein inhibitor 显示文摘 | Riccioni R Dupuis ML Bernabei M | 2010 | Blood Cells Mol Dis2010，45，1： | 1 |
| 5 | The cancer stem cellselective inhibitor salinomycin is apglycoprotein inhibitor 显示文摘 | Riccioni R Dupuis ML Bemabei M | 2010 | BloodCells Mol Dis2010，45，1： | 1 |
| 6 | 6-(7-Nitro-2,1,3- benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated rotein 1-mediated MDR in small cell lung cancer 显示文摘 | Filomeni G Turella P Dupuis ML | 2008 | Mol Cancer Ther2008，7，2： | 1 |
| 7 | Differential effect of HIV-l protease inhibitors on p-glycoprotein function in multidrug-resistant variants of the human CD4+ T lymphoblastoid CEM Cell Line显示文摘 | Tombesi M Sabatini M | 2003 | Chemotherapy2003，49，： | 1 |
| 8 | Selection,affinity maturation,and characterization of a human scFv antibody against CEA protein显示文摘 | Pavoni E Flego M Dupuis ML | 2006 | BMC Cancer2006，6，2： | 1 |
| 9 | The cancer stem cell selective inhibitor salinomycin is a p -glycopro- tein inhibitor显示文摘 | Riccioni R Dupuis ML Bernabei M | 2010 | Blood Cells Mol Dis2010，45，1： | 1 |
| 10 | The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor显示文摘 | Riccioni R Dupuis ML Bernabei M | 2010 | Blood Cells Mol Dis2010，45，1： | 1 |
| 11 | Comparison of health-related quality-of-life outcomes of men and women after coronary artery bypass surgery through 1 year: findings from the POST CABG Biobehavioral Study显示文摘 | Lindquist R Dupuis G Terrin ML | 2003 | Am Heart J2003，146，6： | 1 |
| 12 | Selection,affinity maturation,and characterization of a human scFv antibody against CEA protein显示文摘 | Pavoni E Flego M Dupuis ML | 2006 | BMC Cancer2006，6，： | 1 |
| 13 | The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor显示文摘 | Riccioni R Dupuis ML Bernabei M | 2010 | Blood Cells Mol Dis2010，45，1： | 1 |
| 14 | The glutathioneS-transferase inhibitor 6-( 7-nitro-2, 1,3-benzoxadiazol-4-ylthio) hexanol overcomes the MDR1 -P-glycoprotein andMRP1 -mediated multidrug resistance in acute myeloid leukemiacells显示文摘 | Ascione A Cianfriglia M Dupuis ML | 2009 | Cancer Chemother Pharmacol2009，64，2： | 1 |
| 15 | 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance(MDR) -associated protein 1 -mediated MDR in small cell lungcancer显示文摘 | Filomeni G Turella P Dupuis ML | 2008 | Mol Cancer Ther2008，7，2： | 1 |
| 16 | Sex differences in the as- sociations between lipid levels and incident dementia 显示文摘 | Ancelin ML RiPoche E DuPuy AM | 2013 | J Alzhei- mers Dis2013，34，2： | 1 |
| 17 | 6-(7-Nitro-2, 1,3 benzoxadiazol-4-ylthio) hexanol, a specific glutathione S-trans ferase inhibitor, overcomes the multidrug resistance (MDR)- associated protein 1-mediated MDR in small cell lung cancer 显示文摘 | Filomeni G Turella P Dupuis ML | 2008 | Mol Cancer Ther2008，7，2： | 1 |
| 18 | Selection,affinity maturation,and characterization of a human scFv antibody against CEA protein显示文摘 | Pavoni E Flego M Dupuis ML | 2006 | BMC Cancer2006，6，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员